Cargando…

Comorbidities Before and After the Diagnosis of Rheumatoid Arthritis: A Matched Longitudinal Study

OBJECTIVE: To determine the contribution of rheumatoid arthritis (RA) to conditions and medical events. A secondary objective is to quantify this association before and after the introduction of biologic medications. METHODS: All data were collected as health administrative data in Ontario, Canada. ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tatangelo, Mark R., Tomlinson, George, Keystone, Edward, Paterson, J. Michael, Bansback, Nick, Bombardier, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672304/ https://www.ncbi.nlm.nih.gov/pubmed/33104286 http://dx.doi.org/10.1002/acr2.11182

Ejemplares similares

Health care costs of rheumatoid arthritis: A longitudinal population study
por: Tatangelo, Mark, et al.
Publicado: (2021)

Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage
por: Tatangelo, Mark, et al.
Publicado: (2019)

Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada
por: Movahedi, Mohammad, et al.
Publicado: (2023)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI)
por: Pope, Janet E, et al.
Publicado: (2018)

Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort
por: Movahedi, Mohammad, et al.
Publicado: (2022)

Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis
por: Hazlewood, Glen S, et al.
Publicado: (2016)

Late-onset rheumatoid arthritis has a similar time to remission as younger-onset rheumatoid arthritis: results from the Ontario Best Practices Research Initiative
por: Li, Xiuying, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on patients with rheumatoid arthritis: data from the Ontario Best Practices Research Initiative (OBRI)
por: Wong-Pack, Matthew, et al.
Publicado: (2023)

Cardiovascular risk factors are negatively associated with rheumatoid arthritis disease outcomes
por: Cui, Kangping, et al.
Publicado: (2021)

Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study
por: Panopoulos, Stylianos, et al.
Publicado: (2018)

Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes
por: Da Sylva, Tanya R, et al.
Publicado: (2005)

Adaptation of a Shared Decision-Making Tool for Early Rheumatoid Arthritis Treatment Decisions with Indigenous Patients
por: Umaefulam, Valerie, et al.
Publicado: (2021)

Measuring a grey area in medication deployment reveals delays from invention to clinical use of rheumatoid arthritis medications
por: Tatangelo, Mark
Publicado: (2022)

Identification and Treatment Optimization of Comorbid Depression in Rheumatoid Arthritis
por: Withers, Mellissa H., et al.
Publicado: (2017)

Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individuals
por: Harrison, Mark, et al.
Publicado: (2019)

Validity of the work productivity and activity impairment questionnaire - general health version in patients with rheumatoid arthritis
por: Zhang, Wei, et al.
Publicado: (2010)

Multiparameter Phospho-Flow Analysis of Lymphocytes in Early Rheumatoid Arthritis: Implications for Diagnosis and Monitoring Drug Therapy
por: Galligan, Carole L., et al.
Publicado: (2009)

Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study
por: Zhang, Wei, et al.
Publicado: (2016)

Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis
por: Gualtierotti, Roberta, et al.
Publicado: (2017)

Tools for the Assessment of Comorbidity Burden in Rheumatoid Arthritis
por: Aslam, Fawad, et al.
Publicado: (2018)

TNFα modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts
por: Connor, Alison M, et al.
Publicado: (2012)

Access to rheumatologists among patients with newly diagnosed rheumatoid arthritis in a Canadian universal public healthcare system
por: Widdifield, Jessica, et al.
Publicado: (2014)

An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance
por: Widdifield, Jessica, et al.
Publicado: (2014)

Development of an Implementation Strategy for Patient Decision Aids in Rheumatoid Arthritis Through Application of the Behavior Change Wheel
por: Barber, Claire E. H., et al.
Publicado: (2021)

Making smart investment decisions in clinical research
por: Bansback, Nick, et al.
Publicado: (2015)

Restless Legs Syndrome as a Comorbidity in Rheumatoid Arthritis
por: Gjevre, John A., et al.
Publicado: (2013)

The challenging interplay between rheumatoid arthritis, ageing and comorbidities
por: van Onna, Marloes, et al.
Publicado: (2016)

Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis
por: Bluett, James, et al.
Publicado: (2017)

Comorbidities in Black South Africans with established rheumatoid arthritis
por: Lala, Vikash, et al.
Publicado: (2022)

Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus
por: Fragoulis, George E., et al.
Publicado: (2020)

Long-Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment
por: Alten, Rieke, et al.
Publicado: (2014)

Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study
por: Zhang, Wei, et al.
Publicado: (2015)

On Rheumatoid Arthritis: Its Diagnosis, Pathology, and Treatment
por: Balfour, George W.
Publicado: (1876)

Sodium excretion is higher in patients with rheumatoid arthritis than in matched controls
por: Marouen, Sarah, et al.
Publicado: (2017)

The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review
por: Taylor, Peter C., et al.
Publicado: (2021)

Increased primary care use for musculoskeletal symptoms, infections and comorbidities in the years before the diagnosis of inflammatory arthritis
por: van Beers-Tas, Marian, et al.
Publicado: (2020)

Characterization of active joint count trajectories in juvenile idiopathic arthritis
por: Berard, Roberta A, et al.
Publicado: (2012)

Modified Disease Activity Score at 3 Months Is a Significant Predictor for Rapid Radiographic Progression at 12 Months Compared With Other Measures in Patients With Rheumatoid Arthritis
por: Movahedi, Mohammad, et al.
Publicado: (2020)

Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis
por: Jin, Shangyi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9baqukq5orbvj596otsp6l7q8l